Takafumi Komiyama
Papers
2
Total Citations
11
H-Index
2
About
Dr. Takafumi Komiyama is a radiation oncology researcher whose work focuses on advancing precision in cancer treatment, particularly through surface-guided radiotherapy (SGRT) and stereotactic body radiotherapy (SBRT). His most influential study, published in 2022, rigorously evaluated the detection accuracy of the VOXELAN 3D body scanner for SGRT across various treatment sites using a whole-body human phantom. This work, which has garnered 9 citations, directly addresses a critical clinical need: ensuring reliable patient positioning and motion management during radiotherapy to enhance treatment accuracy and reduce toxicity. By systematically assessing VOXELAN’s performance, Komiyama provides foundational evidence for its clinical adoption, helping to improve safety and efficacy in daily practice. Additionally, his 2019 study on SBRT for lymph node oligometastases contributes to the growing body of evidence supporting ablative, non-invasive treatment for limited metastatic disease. Through these contributions, Komiyama demonstrates a commitment to translating technological innovation into tangible clinical benefits, making him a valuable voice in the evolution of modern radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2Stereotactic Body Radiotherapy for Lymph Node Oligometastases.2 citations · 2019